Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
3.170
+0.080 (2.59%)
At close: Dec 5, 2025, 4:00 PM EST
3.160
-0.010 (-0.32%)
After-hours: Dec 5, 2025, 6:37 PM EST
Atea Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | - | - | - | - | 351.37 | 48.63 | |
| Revenue Growth (YoY) | - | - | - | - | 622.49% | - | |
| Cost of Revenue | 120.09 | 83.37 | 70.61 | 62.39 | 167.21 | 38.02 | |
| Gross Profit | -120.09 | -83.37 | -70.61 | -62.39 | 184.16 | 10.61 | |
| Selling, General & Admin | 39.1 | 48.85 | 49.92 | 48.71 | 45.79 | 21.64 | |
| Operating Expenses | 39.1 | 48.85 | 49.92 | 48.71 | 45.79 | 21.64 | |
| Operating Income | -159.19 | -132.22 | -120.53 | -111.1 | 138.38 | -11.03 | |
| Interest & Investment Income | 18.79 | 25.49 | 29.22 | 11.15 | 0.21 | 0.08 | |
| EBT Excluding Unusual Items | -140.41 | -106.73 | -91.31 | -99.95 | 138.59 | -10.95 | |
| Other Unusual Items | -5.79 | -60.73 | -43.63 | -19.55 | - | - | |
| Pretax Income | -146.19 | -167.46 | -134.94 | -119.5 | 138.59 | -10.95 | |
| Income Tax Expense | 0.83 | 0.93 | 1.02 | -3.59 | 17.4 | - | |
| Net Income | -147.03 | -168.39 | -135.96 | -115.91 | 121.19 | -10.95 | |
| Net Income to Common | -147.03 | -168.39 | -135.96 | -115.91 | 121.19 | -10.95 | |
| Shares Outstanding (Basic) | 83 | 84 | 83 | 83 | 83 | 22 | |
| Shares Outstanding (Diluted) | 83 | 84 | 83 | 83 | 88 | 22 | |
| Shares Change (YoY) | -1.10% | 1.05% | 0.17% | -5.67% | 308.70% | 113.98% | |
| EPS (Basic) | -1.77 | -2.00 | -1.63 | -1.39 | 1.46 | -0.51 | |
| EPS (Diluted) | -1.77 | -2.00 | -1.63 | -1.39 | 1.37 | -0.51 | |
| Free Cash Flow | -134.21 | -135.5 | -85.4 | -122.93 | -87.01 | 296.71 | |
| Free Cash Flow Per Share | -1.61 | -1.61 | -1.02 | -1.48 | -0.99 | 13.74 | |
| Gross Margin | - | - | - | - | 52.41% | 21.82% | |
| Operating Margin | - | - | - | - | 39.38% | -22.68% | |
| Profit Margin | - | - | - | - | 34.49% | -22.51% | |
| Free Cash Flow Margin | - | - | - | - | -24.76% | 610.10% | |
| EBITDA | -158.77 | -131.8 | -120.11 | -110.84 | 138.41 | -11.01 | |
| EBITDA Margin | - | - | - | - | 39.39% | -22.64% | |
| D&A For EBITDA | 0.42 | 0.42 | 0.42 | 0.26 | 0.03 | 0.02 | |
| EBIT | -159.19 | -132.22 | -120.53 | -111.1 | 138.38 | -11.03 | |
| EBIT Margin | - | - | - | - | 39.38% | -22.68% | |
| Effective Tax Rate | - | - | - | - | 12.55% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.